• Skip to navigation (Access key ‘n’)
  • Skip to page content (Access key ‘c’)
National Horizon Scanning Centre logoNational Horizon Scanning Centre
University of Birmingham NHS National Institute for Health Research
  • Home
  • About Us
    • Methods
    • Customers & Partners
    • Glossary
    • Governance
    • Related Links
    • Who's Who?
  • Outputs
    • Outputs by Specialty
    • Research & Publications
    • Other Reports
  • News
  • Suggest a topic
  • Contact Us

More Search Options

Filtering options e.g. by technology type, and for multiple years are available within the results

Mental Health, Drug Abuse and Learning Difficulties

Filter topics in this Specialty Topics can be filtered and/or combined by year of entry, technology type, and other specialties

  • Drug Briefings (12)
  • Diagnostic Briefings (1)
  • Device Briefings (1)
  • Other Reports (0)

Lu AA21004 for major depressive disorder

Date:1 September 2011

Agomelatine (Valdoxan) for generalised anxiety disorder – first or second line

Date:1 April 2011

Loxapine inhalation (Staccato Loxapine) for agitation associated with schizophrenia or bipolar-1 disorder

Date:1 August 2010

Asenapine (Sycrest) for bipolar disorder - manic episodes

Date:1 January 2010

Asenapine (Sycrest) for schizophrenia - acute and maintenance, first or second line

Date:1 January 2010

Risperidone (Risperdal Consta) injection for bipolar 1 disorder - prevention of recurrent mania

Date:1 August 2009

Aripiprazole (Abilify) for major depressive disorder -adjunctive therapy

Date:1 May 2009

Quetiapine (Seroquel XL) for major depressive disorder

Date:1 April 2009

Aripiprazole (Abilify) for bipolar I disorder in children, acute mania

Date:1 December 2008

Aripiprazole (Abilify) for schizophrenia in children

Date:1 December 2008

Amibegron (SR-58611) for depression

Date:1 April 2008

Saredutant, (SR-489686) for depression and anxiety

Date:1 April 2008

ADtect® for the early detection of Alzheimer’s disease

Date:1 June 2010

Transcranial direct current stimulation (tDCS) for major depressive disorder - severe, drug resistant

Date:1 May 2009

NIHR Horizon Scanning Centre, School of Health & Population Sciences, University of Birmingham,
90 Vincent Drive, Edgbaston, Birmingham B15 2SQ
Tel: +44 (0)121 414 7831 Email: nhscadmin@contacts.bham.ac.uk

© University of Birmingham 2000-2012

Made Media Ltd.